Adhering to the concept of "Innovation for Life" and the strategy of innovation-driven development, we are committed to the development of new-generation antibody drugs for the treatment of oncology, autoimmune diseases, cardiovascular diseases, and other major diseases that threaten the life or health of human beings. As a leader in the development of new-generation antibody drugs, the Company has successfully obtained several domestic and international patents in the areas of target development, antibody engineering, therapeutic method development and antibody production, and has filed applications for or entered into the examination stage of a number of other patents.

* Project represents differentiated antibodies